Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial
Cameron, David, Prof, Morden, James P, MSc, Canney, Peter, MD, Velikova, Galina, MD, Coleman, Robert, Prof, Bartlett, John, PhD, Agrawal, Rajiv, FRCR, Banerji, Jane, BHealthSc, Bertelli, Gianfilippo, PhD, Bloomfield, David, MBBS, Brunt, A Murray, Prof, Earl, Helena, Prof, Ellis, Paul, Prof, Gaunt, Claire, BSc, Gillman, Alexa, BSc, Hearfield, Nicholas, BA, Laing, Robert, FRCR, Murray, Nicholas, FRCP, Couper, Niki, BSc, Stein, Robert C, Prof, Verrill, Mark, FRCP, Wardley, Andrew, Prof, Barrett-Lee, Peter, Prof, Bliss, Judith M, Prof
Published in The lancet oncology (01.07.2017)
Published in The lancet oncology (01.07.2017)
Get full text
Journal Article
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
Ellis, Paul, Dr, Barrett-Lee, Peter, Prof, Johnson, Lindsay, BSc, Cameron, David, Prof, Wardley, Andrew, MD, O'Reilly, Susan, MD, Verrill, Mark, FRCP, Smith, Ian, Prof, Yarnold, John, Prof, Coleman, Robert, Prof, Earl, Helena, FRCP, Canney, Peter, MD, Twelves, Chris, Prof, Poole, Christopher, Prof, Bloomfield, David, FRCR, Hopwood, Penelope, Prof, Johnston, Stephen, FRCP, Dowsett, Mitchell, Prof, Bartlett, John MS, Prof, Ellis, Ian, Dr, Prof, Peckitt, Clare, MSc, Hall, Emma, PhD, Bliss, Judith M, Prof
Published in The Lancet (British edition) (16.05.2009)
Published in The Lancet (British edition) (16.05.2009)
Get full text
Journal Article